See more : Oki Electric Industry Co., Ltd. (6703.T) Income Statement Analysis – Financial Results
Complete financial analysis of Curaleaf Holdings, Inc. (CURA.CN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Curaleaf Holdings, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Tassal Group Limited (TGR.AX) Income Statement Analysis – Financial Results
- D’Ieteren Group SA (SIETY) Income Statement Analysis – Financial Results
- Hefei Meyer Optoelectronic Technology Inc. (002690.SZ) Income Statement Analysis – Financial Results
- Kewaunee Scientific Corporation (KEQU) Income Statement Analysis – Financial Results
- DBT SA (ALDBT.PA) Income Statement Analysis – Financial Results
Curaleaf Holdings, Inc. (CURA.CN)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.curaleaf.com
About Curaleaf Holdings, Inc.
Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates in two segments, Cannabis Operations and Non-Cannabis Operations. The Cannabis Operations segment engages in the production and sale of cannabis through retail and wholesale channels. The Non-Cannabis Operations segment provides professional services, including cultivation, processing, and retail know-how and back-office administration, intellectual property licensing, real estate leasing services, and lending facilities to medical and adult-use cannabis licensees under management service agreements. It offers flowers, pre-rolls, flower pods, and dry-herb vaporizer cartridges; concentrates for vaporizing, such as pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, including distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. The company also provides hemp-based CBD products. As of November 22, 2022, it operated 144 dispensaries and 29 cultivation sites in 21 states of the United States. The company was founded in 2010 and is headquartered in Wakefield, Massachusetts.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.34B | 1.21B | 626.64M | 221.02M | 77.06M | 19.31M | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 757.31M | 522.07M | 236.12M | 79.41M | 30.77M | 3.72M | 0.00 | 0.00 | 0.00 |
| Gross Profit | 579.03M | 687.59M | 390.51M | 141.61M | 46.29M | 15.60M | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 43.33% | 56.84% | 62.32% | 64.07% | 60.07% | 80.76% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 26.76K | 0.00 | 0.00 |
| General & Administrative | 430.95M | 373.90M | 234.88M | 125.44M | 63.28M | 17.39M | 91.42K | 159.35K | 45.33K |
| Selling & Marketing | 44.61M | 41.84M | 23.27M | 12.19M | 4.26M | 1.54M | 0.00 | 2.03K | 1.69K |
| SG&A | 475.56M | 415.74M | 258.15M | 137.63M | 67.54M | 18.93M | 91.42K | 161.38K | 47.02K |
| Other Expenses | 115.85M | 96.22M | 68.68M | 31.70M | -25.05M | 259.00K | 0.00 | 598.12 | 1.01K |
| Operating Expenses | 591.40M | 511.96M | 326.83M | 169.33M | 74.97M | 22.14M | 118.18K | 161.38K | 47.02K |
| Cost & Expenses | 1.35B | 1.03B | 562.95M | 248.74M | 105.74M | 25.86M | 118.18K | 161.38K | 47.02K |
| Interest Income | 137.00K | 629.00K | 6.48M | 9.94M | 4.81M | 2.99M | 0.00 | 0.00 | 0.00 |
| Interest Expense | 93.33M | 90.26M | 69.00M | 24.75M | 7.31M | 1.59M | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 176.47M | 134.13M | 96.37M | 37.21M | 8.65M | 3.73M | 22.82K | 0.00 | 0.00 |
| EBITDA | 166.23M | 179.12M | 160.05M | 16.17M | -12.30M | -1.99M | -1.10M | -161.38K | -47.02K |
| EBITDA Ratio | 12.44% | 25.61% | 25.54% | 7.32% | -52.26% | 2.23% | 0.00% | 0.00% | 0.00% |
| Operating Income | -10.25M | 175.63M | 63.68M | -21.04M | -28.68M | -6.55M | -118.18K | -161.38K | -47.02K |
| Operating Income Ratio | -0.77% | 14.52% | 10.16% | -9.52% | -37.22% | -33.89% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -214.06M | 6.22M | -41.64M | -24.75M | -27.55M | 1.68M | 1.02M | 598.12 | 1.01K |
| Income Before Tax | -226.43M | 64.80M | 22.04M | -45.79M | -56.23M | -3.98M | -118.18K | -160.78K | -46.02K |
| Income Before Tax Ratio | -16.94% | 5.36% | 3.52% | -20.72% | -72.98% | -20.59% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 150.50M | 173.93M | 83.37M | 24.06M | 5.64M | 1.07M | 0.00 | 0.00 | 0.00 |
| Net Income | -376.93M | -109.13M | -61.33M | -69.85M | -56.47M | -2.82M | -118.18K | -160.78K | -46.02K |
| Net Income Ratio | -28.21% | -9.02% | -9.79% | -31.60% | -73.28% | -14.59% | 0.00% | 0.00% | 0.00% |
| EPS | -0.53 | -0.16 | -0.11 | -0.15 | -0.14 | -0.01 | -0.10 | -0.20 | -0.06 |
| EPS Diluted | -0.53 | -0.16 | -0.11 | -0.15 | -0.14 | -0.01 | -0.10 | -0.20 | -0.06 |
| Weighted Avg Shares Out | 711.16M | 698.76M | 557.19M | 462.91M | 396.50M | 322.83M | 1.15M | 817.81K | 740.00K |
| Weighted Avg Shares Out (Dil) | 711.16M | 698.76M | 557.19M | 462.91M | 396.50M | 322.83M | 1.15M | 817.81K | 740.00K |
Source: https://incomestatements.info
Category: Stock Reports